The development of a novel PARP inhibitor with potent antitumor activity in various tumor xenograft models

被引：0
|
作者：
Park, Ji-Seon [1 ]
Kim, Jang-Hyun [1 ]
Cheon, Kwang-Woo [1 ]
Cho, Bo-Young [1 ]
Kim, Kang-Jeon [1 ]
Lee, Han-Chang [1 ]
Kim, Young-Cheol [1 ]
Oh, Hyung-Chan [1 ]
Lee, Hyun-Ho [1 ]
Kim, Jeong-Min [1 ]
机构：
[1] JEIL Pharm, Yongin, South Korea
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-825
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
825
引用
收藏
页数：1
相关论文
共 50 条
  • [11] PARP inhibitor has antitumor activity
    Mandy Aujla
    Nature Reviews Clinical Oncology, 2009, 6 (9) : 496 - 496
  • [12] Evaluation of antitumor activity of a novel PI3K inhibitor ZSTK474 by various human cancer xenograft models
    Yamori, T.
    Okamura, M.
    EJC SUPPLEMENTS, 2008, 6 (12): : 71 - 71
  • [13] GSK1070916, a potent Aurora B/C kinase inhibitor with broad antitumor activity in tissue culture cells and human tumor xenograft models
    Hardwicke, Mary Ann
    Oleykowski, Catherine A.
    Plant, Ramona
    Wang, Jamin
    Liao, Qiaoyin
    Moss, Katherine
    Newlander, Ken
    Adams, Jerry L.
    Dhanak, Dashyant
    Yang, Jingsong
    Lai, Zhihong
    Sutton, David
    Patrick, Denis
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (07) : 1808 - 1817
  • [14] ASN002: A novel dual SYK/JAK inhibitor with strong antitumor activity in both hematological and solid tumor xenograft models
    Reddy, Sanjeeva P.
    Rao, Niranjan
    Zammit, David
    Thompson, Scott K.
    Smith, Roger A.
    Denis, Louis
    CANCER RESEARCH, 2017, 77
  • [15] Antitumor activity of erlotinib in combination with capecitabine in human tumor xenograft models
    Ouchi, KF
    Yanagisawa, M
    Sekiguchi, F
    Tanaka, Y
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (05) : 693 - 702
  • [16] Antitumor activity of erlotinib in combination with capecitabine in human tumor xenograft models
    Kaori F. -Ouchi
    Mieko Yanagisawa
    Fumiko Sekiguchi
    Yutaka Tanaka
    Cancer Chemotherapy and Pharmacology, 2006, 57 : 693 - 702
  • [17] Novel Microtubule Polymerization Inhibitor with Potent Antiproliferative and Antitumor Activity
    Arora, Sonia
    Wang, Xin I.
    Keenan, Susan M.
    Andaya, Christina
    Zhang, Qiang
    Peng, Youyi
    Welsh, William J.
    CANCER RESEARCH, 2009, 69 (05) : 1910 - 1915
  • [18] Antitumor activity of a novel small molecule agent PRLX 93936 against human tumor xenograft models
    Robbins, Paul
    Clemens, Chris
    Pierce, Michael
    Peltier, John
    Selliah, Robert
    Venkat, Raj Gopal
    Rebentisch, Matt
    Lai, Shuping
    Becklin, Robert
    Senina, Anna
    O'Mel, Vlad
    Erkkila, Tracy
    Sahasrabudhe, Sudhir R.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3444S - 3444S
  • [19] A Novel CDK9 Inhibitor Shows Potent Antitumor Efficacy in Preclinical Hematologic Tumor Models
    Yin, Tinggui
    Lallena, Maria J.
    Kreklau, Emiko L.
    Fales, Kevin R.
    Carballares, Santiago
    Torrres, Raquel
    Wishart, Graham N.
    Ajamie, Rose T.
    Cronier, Damien M.
    Iversen, Phillip W.
    Meier, Timothy I.
    Foreman, Robert T.
    Zeckner, Douglas
    Sissons, Sean E.
    Halstead, Bart W.
    Lin, Aimee B.
    Donoho, Gregory P.
    Qian, Yuewei
    Li, Shuyu
    Wu, Song
    Aggarwal, Amit
    Ye, Xiang S.
    Starling, James J.
    Gaynor, Richard B.
    de Dios, Alfonso
    Du, Jian
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (06) : 1442 - 1456
  • [20] Effects of the novel BET inhibitor BI 894999 on upregulation of HEXIM1 in cancer cells and on antitumor activity in xenograft tumor models.
    Tontsch-Grunt, Ulrike
    Savarese, Fabio
    Baum, Anke
    Scharn, Dirk
    Gerlach, Daniel
    Hofmann, Marco H.
    Kaya, Onur
    Schweifer, Norbert
    Engelhardt, Harald
    Musa, Hanny
    Le, Chooi Peng
    Munzert, Gerd Michael
    Kraut, Norbert
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345